Latest Breaking News On - Graham gulbransen - Page 2 : comparemela.com
Most medicinal cannabis users buy on the black market – report
stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
More tales from the Medicinal Cannabis Scheme • Hard News • Public Address
publicaddress.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicaddress.net Daily Mail and Mail on Sunday newspapers.
GUEST BLOG: Tadhg Stopford – What is Tigerdrops Holy Hemp CBD oil?
thedailyblog.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyblog.co.nz Daily Mail and Mail on Sunday newspapers.
New Zealand is facing a collapse of legal medicinal cannabis supply after March 31, when a deadline to meet stiff new government rules is expected to keep the products of three of the country’s five main importers out of the market, reports NZ Herald’s Kate MacNamara in this Herald Premium article.
Last April, the government unveiled a new regulatory system to create more safe, widespread and affordable access to medicinal cannabis. It has not yet approved a single product.
New Zealand-based importers Medleaf Therapeutics, Nubu Pharmaceuticals, and Eqalis Pharmaceuticals confirmed their products are not likely to be approved under the new standards before the March deadline. Domestic production, still in its very early stages, is not likely to reach the market until late this year.
New Zealand s medicinal cannabis supply in jeopardy
5 Feb, 2021 04:27 AM
6 minutes to read
NZ Herald
By: Kate MacNamara New Zealand is facing a collapse of legal medicinal cannabis supply after March 31st, when a deadline to meet stiff new government rules is expected to keep the products of three of the country s five main importers out of the market.
Last April, the Government unveiled a new regulatory system to create more safe, widespread and affordable access to medicinal cannabis, it has not yet approved a single product.
New Zealand-based importers Medleaf Therapeutics, Nubu Pharmaceuticals, and Eqalis Pharmaceuticals confirmed their products are not likely to be approved under the new standards before the March deadline. Domestic production, still in its very early stages, is not likely to reach the market until late this year.